CathLab.com is a site created by healthcare professionals for healthcare professionals.
We serve cardiac and vascular nurses, technologists, educators, managers, and directors. In a field that is continually evolving, CathLab.com is the industry professional’s #1 resource for product insights, news, education and job opportunities.
Find a Job
Five-year results from the randomized REDUCE trial show a continued benefit of patent foramen ovale (PFO) closure compared with antiplatelet therapy alone for the prevention of cryptogenic stroke.
Beta-blockers treat various cardiovascular diseases and were not more likely to cause depression compared to other similar treatments, according to new research published today in Hypertension, an American Heart Association journal. While depression may occur during beta-blocker therapy, the research suggests beta-blockers are not the likely cause.
SCAI Operationalizing Efficiency, Cost-Effectiveness, and Innovation During a Pandemic
Cath Lab Logistics: Balancing Elective, Urgent and Emergent Cases Across the Spectrum of Interventional Procedures.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!